Rossari Biotech Limited

NSEI:ROSSARI Stock Report

Market Cap: ₹48.4b

Rossari Biotech Valuation

Is ROSSARI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ROSSARI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ROSSARI (₹875.8) is trading above our estimate of fair value (₹501.99)

Significantly Below Fair Value: ROSSARI is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ROSSARI?

Other financial metrics that can be useful for relative valuation.

ROSSARI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.6x
Enterprise Value/EBITDA19.2x
PEG Ratio1.7x

Price to Earnings Ratio vs Peers

How does ROSSARI's PE Ratio compare to its peers?

The above table shows the PE ratio for ROSSARI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average66.3x
505710 Grauer & Weil (India)
31.5xn/a₹50.4b
FCL Fineotex Chemical
37x31.2%₹45.4b
NEOGEN Neogen Chemicals
144.2x36.4%₹53.9b
INDIGOPNTS Indigo Paints
52.4x15.3%₹74.6b
ROSSARI Rossari Biotech
35.5x20.4%₹48.4b

Price-To-Earnings vs Peers: ROSSARI is good value based on its Price-To-Earnings Ratio (35.5x) compared to the peer average (66.3x).

Price to Earnings Ratio vs Industry

How does ROSSARI's PE Ratio compare vs other companies in the IN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.1%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.1%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: ROSSARI is good value based on its Price-To-Earnings Ratio (35.5x) compared to the Indian Chemicals industry average (36.2x).

Price to Earnings Ratio vs Fair Ratio

What is ROSSARI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ROSSARI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio35.5x
Fair PE Ratio27.7x

Price-To-Earnings vs Fair Ratio: ROSSARI is expensive based on its Price-To-Earnings Ratio (35.5x) compared to the estimated Fair Price-To-Earnings Ratio (27.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ROSSARI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹875.80
₹951.25
+8.6%
5.6%₹1,034.00₹885.00n/a4
Oct ’25₹905.80
₹951.25
+5.0%
5.6%₹1,034.00₹885.00n/a4
Sep ’25₹880.95
₹925.50
+5.1%
2.6%₹950.00₹885.00n/a4
Aug ’25₹871.65
₹925.50
+6.2%
2.6%₹950.00₹885.00n/a4
Jul ’25₹845.65
₹884.25
+4.6%
6.8%₹950.00₹810.00n/a4
Jun ’25₹689.70
₹862.33
+25.0%
6.2%₹936.00₹810.00n/a3
May ’25₹749.25
₹907.00
+21.1%
3.7%₹936.00₹860.00n/a3
Apr ’25₹699.90
₹911.67
+30.3%
4.2%₹950.00₹860.00n/a3
Mar ’25₹743.20
₹911.67
+22.7%
4.2%₹950.00₹860.00n/a3
Feb ’25₹792.05
₹911.67
+15.1%
4.2%₹950.00₹860.00n/a3
Jan ’25₹799.25
₹781.50
-2.2%
7.9%₹843.00₹720.00n/a2
Dec ’24₹759.45
₹781.50
+2.9%
7.9%₹843.00₹720.00n/a2
Nov ’24₹732.60
₹781.50
+6.7%
7.9%₹843.00₹720.00n/a2
Oct ’24₹814.65
₹853.50
+4.8%
15.1%₹982.00₹725.00₹905.802
Sep ’24₹855.95
₹853.50
-0.3%
15.1%₹982.00₹725.00₹880.952
Aug ’24₹843.70
₹853.50
+1.2%
15.1%₹982.00₹725.00₹871.652
Jul ’24₹869.85
₹831.00
-4.5%
18.2%₹982.00₹680.00₹845.652
Jun ’24₹746.85
₹831.00
+11.3%
18.2%₹982.00₹680.00₹689.702
May ’24₹686.80
₹847.00
+23.3%
15.0%₹974.00₹720.00₹749.252
Apr ’24₹596.10
₹847.00
+42.1%
15.0%₹974.00₹720.00₹699.902
Mar ’24₹616.95
₹847.00
+37.3%
15.0%₹974.00₹720.00₹743.202
Feb ’24₹690.90
₹1,061.00
+53.6%
18.0%₹1,252.00₹870.00₹792.052
Jan ’24₹727.15
₹1,061.00
+45.9%
18.0%₹1,252.00₹870.00₹799.252
Dec ’23₹804.45
₹1,061.00
+31.9%
18.0%₹1,252.00₹870.00₹759.452
Nov ’23₹893.75
₹1,086.00
+21.5%
15.3%₹1,252.00₹920.00₹732.602
Oct ’23₹970.00
₹1,086.00
+12.0%
15.3%₹1,252.00₹920.00₹814.652

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y